90
Participants
Start Date
June 29, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Rituximab infusion
2 infusions of 1 gram of rituximab at a 2 week interval (day 1 followed by day 15).
Placebo infusion
2 infusions of placebo at a 2 week interval.
Premedications
"Premedications prior to rituximab or placebo infusions:~* IV Dexchlorpheniramine Maleate IV: 10 mg~* IV Methylprednisolone: 40 mg~* PO Paracetamol : 1 gram"
NOT_YET_RECRUITING
CHU La Timone - APHM, Marseille
NOT_YET_RECRUITING
CHU Brest - La cavale blanche, Brest
NOT_YET_RECRUITING
CHU Toulouse - Pierre-Paul Riquet, Toulouse
NOT_YET_RECRUITING
CHU Tours - Bretonneau, Tours
NOT_YET_RECRUITING
CHU Grenoble - La tronche, Grenoble
NOT_YET_RECRUITING
CHU Nancy- Hôpital central, Nancy
NOT_YET_RECRUITING
CHU Lille - Roger Salengro, Lille
NOT_YET_RECRUITING
CHU Strasbourg - Hautepierre, Strasbourg
NOT_YET_RECRUITING
HCL lyon, Lyon
NOT_YET_RECRUITING
APHP Pitié Salpêtrière, Paris
NOT_YET_RECRUITING
CHU Limoges - Dupuytren, Limoges
NOT_YET_RECRUITING
APHP - Kremlin-Bicêtre, Paris
NOT_YET_RECRUITING
Hôtel-Dieu et Hôpital GR Laënnec - CHU Nantes, Nantes
RECRUITING
CHU de Saint-Etienne, Saint-Etienne
NOT_YET_RECRUITING
CHU Nice - Pasteur, Nice
Ministry of Health, France
OTHER_GOV
Centre Hospitalier Universitaire de Saint Etienne
OTHER